Innospec (IOSP) Sets New 52-Week High and Low at $74.35

Innospec (NASDAQ:IOSP) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $74.35 and last traded at $73.90, with a volume of 18594 shares. The stock had previously closed at $72.70.

Several equities research analysts recently commented on IOSP shares. BidaskClub raised shares of Innospec from a “sell” rating to a “hold” rating in a research note on Wednesday, December 27th. Zacks Investment Research lowered shares of Innospec from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. Finally, ValuEngine raised shares of Innospec from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $70.50.

How to Become a New Pot Stock Millionaire

The company has a current ratio of 2.15, a quick ratio of 1.34 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $1,818.60, a PE ratio of 15.84 and a beta of 1.03.

Innospec (NASDAQ:IOSP) last issued its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.34. The business had revenue of $353.80 million during the quarter. Innospec had a net margin of 4.73% and a return on equity of 15.57%. analysts predict that Innospec will post 4.3 EPS for the current fiscal year.

In other Innospec news, VP Philip John Boon sold 501 shares of Innospec stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $67.04, for a total value of $33,587.04. Following the completion of the transaction, the vice president now directly owns 35,439 shares of the company’s stock, valued at $2,375,830.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Ian Cleminson sold 2,261 shares of Innospec stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $68.55, for a total transaction of $154,991.55. Following the completion of the transaction, the chief financial officer now directly owns 26,685 shares of the company’s stock, valued at $1,829,256.75. The disclosure for this sale can be found here. Insiders sold 12,112 shares of company stock valued at $832,724 over the last ninety days. Corporate insiders own 2.02% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in IOSP. C M Bidwell & Associates Ltd. purchased a new position in shares of Innospec during the fourth quarter valued at approximately $142,000. Xact Kapitalforvaltning AB purchased a new position in shares of Innospec during the fourth quarter valued at approximately $222,000. SG Americas Securities LLC raised its holdings in shares of Innospec by 130.5% during the third quarter. SG Americas Securities LLC now owns 3,738 shares of the specialty chemicals company’s stock valued at $230,000 after purchasing an additional 2,116 shares during the last quarter. Amalgamated Bank purchased a new position in shares of Innospec during the fourth quarter valued at approximately $245,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Innospec during the fourth quarter valued at approximately $258,000. 90.83% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/04/20/innospec-iosp-sets-new-52-week-high-and-low-at-74-35.html.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply